Showing 346 to 360 of 849 results
Making an appeal
If we decide that your CPD profile does not meet our standards you can appeal against this decision
Failure to maintain adequate records
Case study: A dietitian’s employer raised concerns about their clinical practice and conduct, following a number of incidents relating to six different service users.
What employers need to know about our consultation on the Standards of proficiency
HCPC research on effective clinical and peer supervision in the workplace
Using the Multiple Registrant Search tool
Step-by-step instructions for using the Multiple Registrant Search (MRS)
Concerns about employees
If a concern is raised about an employee, we may ask you for information as their employer or manager
Fitness to practise decisions
Information for those wishing to make a complaint about a decision included in the outcome of a fitness to practise case.
Service announcement: Friday 19 July 2024
Offices will be closed on Friday 19 July 2024 for all-staff training. Our telephone and email services will not be available.
My Story - Avril Platt (AHPs' Day 2023)
Professional practice practitioner and AHP Avril Platt gives us an insight into how a team of AHPs all work together.
Level of supervision
Case study: Ameena is a registered Band 7 Physiotherapist at an NHS Trust. Ameena has recently been asked by her employer to supervise Marianne, who has recently qualified as a Band 5 physiotherapist.
My story - Sonya Lam
To celebrate Allied Health Professions (AHPs) day, Sonya talks to us about what it means to be an AHP and how she is inspired by the talent and resourcefulness of other AHPs.
We've launched our new data hub
Our new data hub, provides a valuable insight into the 15 health and care professions that we regulate.
Comparison tables
The changes between the previous standards and the updated standards are set out in these comparison tables.
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).